HBP.TO
Helix Biopharma Corp
Price:  
0.24 
CAD
Volume:  
30,860.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBP.TO Fair Value

-150.80 %
Upside

As of 2024-06-24, the Fair Value of Helix Biopharma Corp (HBP.TO) is -0.12 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.24 CAD, the upside of Helix Biopharma Corp is -150.80%.

Note: valuation result may not be accurate due to the company's negative EPS.

0.24 CAD
Stock Price
-0.12 CAD
Fair Price
FAIR VALUE CALCULATION

HBP.TO Fair Value

Peter Lynch's formula is:

HBP.TO Fair Value
= Earnings Growth Rate x TTM EPS
HBP.TO Fair Value
= 5.29 x -0.02
HBP.TO Fair Value
= -0.12

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-07-31 2020-07-31 2021-07-31 2022-07-31 2023-07-31 5Y Avg
Net income -7.53 -8.99 -8.04 -6.56 -6.29 -7.48
YoY growth 12.75% -19.39% 10.59% 18.34% 4.17% 5.29%

HBP.TO Fair Value - Key Data

Market Cap (mil) 58.83
P/E
Forward P/E
EPS -0.02
Avg earnings growth rate 5.29%
TTM earnings -5.65